Fortfahren mit
D8517
Eisen-Dextran
95-105 mg/mL (Iron content), solution
Synonym(e):
Ferric hydroxide dextran complex
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 25 mL | Warenkorb auf Verfügbarkeit prüfen | € 176,00 | |
| 100 mL | Warenkorb auf Verfügbarkeit prüfen | € 455,00 |
Über diesen Artikel
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenbiological source
synthetic
Quality Level
sterility
aseptically filled
assay
95-105 mg/mL (Iron content)
form
solution
contains
0.5% phenol as preservative
composition
Iron, ~100 mg/mL
color
brown
useful pH range
4 - 6.5
storage temp.
room temp
SMILES string
[Fe].[S](=O)(=O)(O)O
InChI
1S/Fe.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)
InChI key
MVZXTUSAYBWAAM-UHFFFAOYSA-N
Application
Other Notes
To gain a comprehensive understanding of our extensive range of Dextrans for your research, we encourage you to visit our Carbohydrates Category page.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| biological source synthetic | biological source synthetic | biological source synthetic | biological source synthetic |
| assay 95-105 mg/mL (Iron content) | assay - | assay - | assay - |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| form solution | form powder | form powder | form powder |
| storage temp. room temp | storage temp. - | storage temp. −20°C | storage temp. −20°C |
| color brown | color - | color - | color - |
hcodes
signalword
Danger
Hazard Classifications
Carc. 1B - Skin Sens. 1
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Zachariah DeFilipp et al.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 9(1), 129-132 (2012-08-08)
Iron deficiency is a major postoperative complication of Roux-en-Y gastric bypass surgery. Oral replacement can fail to correct the deficiency. Thus, recourse to parenteral iron administration might be necessary. Our objective was to evaluate the effectiveness and safety of a
C Egger et al.
Ultraschall in der Medizin (Stuttgart, Germany : 1980), 33(6), 587-592 (2012-11-17)
To check the feasibility of the easy quantification of tumor vascularization derived from dynamic contrast-enhanced ultrasound (DCE-US) in comparison to dynamic contrast-enhanced computed tomography (DCE-CT) in patients with hepatocellular carcinoma (HCC). 19 patients with cirrhosis and histologically proven HCC prospectively
Maureen M Okam et al.
American journal of hematology, 87(11), E123-E124 (2012-09-12)
Oral iron replacement is the standard therapy in iron-deficiency anemia (IDA). However, 59% of patients have gastrointestinal toxicity. With impaired iron uptake from the gastrointestinal tract (in anemia of chronic disease (ACD) or after bariatric surgery), suboptimal responsiveness to exogenous
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D8517-25ML | 04061833589694 |
| D8517-100ML | 04061833589687 |